RedHill's Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-R... - 16 December 2020 02:07

TEL AVIV, Israel and RALEIGH, N.C., December 15, 2020, /PRNewswire-AsiaNet/-- RedHill Biopharma Ltd. [https://www.redhillbio.com/RedHill/ ] (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced promising preliminary results from a preclinical study within which opaganib, a nove...

  ADC Therapeutics and Overland Pharma Form Strategic JV to Expa... - 16 December 2020 01:00

NEW YORK, Dec. 16, 2020 /PRNewswire-AsiaNet/ -- M.S.Q. Ventures ("MSQ") is pleased to announce that its client, ADC Therapeutics SA (NYSE: ADCT), has successfully entered into an agreement to jointly form a new company, Overland ADCT BioPharma (CY) Limited with Overland Pharmaceuticals, a fully...

  INOVIO to Develop DNA-encoded Monoclonal Antibody (dMAb(R)) Ca... - 16 December 2020 00:00

PLYMOUTH MEETING, Pa., Dec. 15, 2020 /PRNewswire-AsiaNet/ -- -- DARPA to fund innovative public-private partnership between INOVIO, The Wistar Institute, AstraZeneca, the University of Pennsylvania and Indiana University -- $37.6 million grant from DARPA will leverage AstraZeneca's monocl...

  Sai Life Sciences releases its first Sustainability Report - 14 December 2020 21:11

Hyderabad, India, Dec. 14, 2020 /PRNewswire-AsiaNet/ -- - Developed as per the Global Reporting Initiative (GRI) standards - Highlights the various sustainable choices embraced by the company in steering its journey on a sustainable path Sai Life Sciences, one of India’s fastest growing Contra...

  High prevalence of hospital malnutrition associated with poor ... - 14 December 2020 13:00

BAD HOMBURG, Germany, Dec. 14, 2020 /PRNewswire-AsiaNet/ -- Hospital malnutrition is documented in many observational studies from the United States, Europe, and Latin America. A recently published literature review found that malnutrition is highly prevalent across different hospital patient groups in 11 ...

  The EspeRare Foundation and Pierre Fabre join forces to develo... - 14 December 2020 09:00

GENEVA and CASTRES, France, Dec. 14, 2020 /PRNewswire-AsiaNet/ -- The EspeRare Foundation and the Pierre Fabre group announced today that they have entered into a license and development collaboration agreement for the development and commercialization of ER-004, a prenatal treatment for XLHED (X-linked Hypohidr...

  AGS Health Recognized in KLAS(R) Report - 12 December 2020 03:49

OLYPHANT, Pa., Dec. 11, 2020 /PRNewswire-AsiaNet/ -- -- "Outsourced Coding 2020, Which Firms Deliver Quality and Value" AGS Health, a leader in revenue cycle management services for major healthcare providers across the U.S. today announced it has been recognized by KLAS(R) Research as a "consist...

  Catalent Appoints Nakaya Matsumaru as General Manager of its N... - 11 December 2020 13:30

SOMERSET, N.J., Dec. 11, 2020 /PRNewswire-AsiaNet/ -- Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Nakay...

  DETECT program studies validate clinical relevance of CTC HER2... - 11 December 2020 01:12

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 10, 2020 /PRNewswire-AsiaNet/ -- - Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome Me...

  INOVIO and Advaccine Announce First Dosing of Subject in Phase... - 11 December 2020 00:00

PLYMOUTH MEETING, Pa. and SUZHOU, China, Dec. 10, 2020 /PRNewswire-AsiaNet/ -- -- Dosing marks a key milestone for INO-4800 in China and its second Phase 2 clinical trial globally INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...